Innovent Biologics, Inc. (IVBXF)

Innovent Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,899	7,719	8,875	6,592	9,047	14,845
Market Cap Growth	202.17%	-13.03%	34.63%	-27.13%	-39.06%	244.95%
Enterprise Value	19,035	6,988	8,174	5,758	7,612	14,106
Last Close Price	11.45	4.50	4.92	4.29	6.15	10.25
PS Ratio	12.48	5.98	10.14	9.98	13.46	25.21
PB Ratio	9.88	4.30	5.02	4.24	5.56	11.04
P/TBV Ratio	10.94	4.40	5.04	4.25	5.57	11.04
P/FCF Ratio	98.47	175.32	-	-	-	-
P/OCF Ratio	78.48	43.78	425.78	-	-	-
EV/Sales Ratio	11.89	5.41	9.34	8.72	11.33	23.96
EV/EBITDA Ratio	107.42	2126.28	-	-	-	-
EV/FCF Ratio	94.19	158.73	-	-	-	-
Debt / Equity Ratio	0.23	0.22	0.29	0.30	0.24	0.14
Debt / EBITDA Ratio	2.54	50.93	-	-	-	-
Debt / FCF Ratio	2.33	8.81	-	-	-	-
Asset Turnover	0.52	0.45	0.33	0.27	0.30	0.40
Inventory Turnover	2.94	2.69	1.51	1.00	1.19	1.45
Quick Ratio	2.25	2.08	2.68	2.78	3.27	5.85
Current Ratio	2.61	2.35	3.00	3.29	3.79	6.37
Return on Equity (ROE)	8.43%	-0.74%	-8.84%	-20.70%	-28.56%	-14.75%
Return on Assets (ROA)	2.65%	-0.82%	-5.12%	-11.54%	-12.04%	-3.65%
Return on Capital Employed (ROCE)	5.00%	-1.60%	-9.70%	-22.20%	-20.50%	-5.40%
Earnings Yield	0.79%	-0.17%	-1.63%	-4.79%	-4.75%	-1.03%
FCF Yield	1.02%	0.57%	-1.54%	-6.19%	-5.38%	-0.82%
Buyback Yield / Dilution	-3.74%	-4.35%	-4.67%	-2.37%	-7.27%	-15.23%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.